Financials

News Ideas Technicals

ALVET fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to THERAVET operating, investing, and financing activities

ALVET free cash flow for H2 23 is -433.12 k EUR. For 2023, ALVET free cash flow was -1.23 M EUR and operating cash flow was -1.23 M EUR.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—